Share Price and Basic Stock Data
Last Updated: January 17, 2026, 7:20 am
| PEG Ratio | 0.72 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Krishana Phoschem Ltd, operating in the fertilisers sector, reported a robust revenue growth trajectory, with sales rising from ₹65 Cr in September 2022 to ₹265 Cr by September 2023. This upward trend continued as sales were recorded at ₹1,355 Cr for the fiscal year ending March 2025, marking a remarkable increase from ₹323 Cr in March 2023. The trailing twelve months (TTM) revenue stood at ₹1,780 Cr, reflecting strong operational performance. The company’s quarterly sales figures indicate consistent growth, peaking at ₹608 Cr in September 2025. This growth can be attributed to the increased demand in the fertiliser sector, which is anticipated to benefit from the ongoing agricultural reforms in India. As Krishana Phoschem navigates this landscape, its ability to sustain this revenue growth will be crucial in maintaining its competitive edge within the industry.
Profitability and Efficiency Metrics
Krishana Phoschem’s profitability metrics reveal a mixed performance. The operating profit margin (OPM) stood at 12% for the current fiscal year, although it showed fluctuations over recent quarters, peaking at 24% in September 2022. Net profit for the year ending March 2025 rose to ₹87 Cr, up from ₹27 Cr in March 2023, reflecting an improving efficiency in cost management amidst rising revenues. The return on equity (ROE) reached 25.3%, while the return on capital employed (ROCE) recorded at 21.7%, both indicating effective utilization of capital. However, the company faces challenges with its cash conversion cycle (CCC), which stood at 95 days, reflecting potential inefficiencies in working capital management. While Krishana Phoschem showcases strong profitability metrics, improving operational efficiency will be essential to sustain these gains.
Balance Sheet Strength and Financial Ratios
The balance sheet of Krishana Phoschem Ltd indicates a solid financial foundation, with total assets recorded at ₹1,270 Cr as of September 2025. The company’s borrowings are at ₹413 Cr, leading to a debt-to-equity ratio of 0.97, suggesting a balanced approach to leveraging. Reserves have increased significantly to ₹383 Cr, enhancing the company’s financial stability. The interest coverage ratio (ICR) is reported at 4.91x, which highlights the firm’s ability to meet interest obligations from its operating income. However, the price-to-book value ratio (P/BV) stands at 3.79x, reflecting a premium valuation compared to typical sector margins. This could indicate that the market is pricing in future growth expectations, which might be put to the test if profitability does not align with such valuations. Overall, while Krishana Phoschem maintains a sound balance sheet, it must navigate its valuation carefully to retain investor confidence.
Shareholding Pattern and Investor Confidence
Krishana Phoschem’s shareholding pattern reveals a strong promoter backing, with promoters holding 71.96% of the company as of September 2025. This ownership level has gradually increased from 64.83% in December 2022, indicating growing confidence from the promoters in the company’s future prospects. The public shareholding stands at 27.44%, while foreign institutional investors (FIIs) represent a modest 0.60%. The increase in the number of shareholders from 6,289 in December 2022 to 13,987 by September 2025 reflects a growing interest among retail investors. This trend is crucial as it may imply increased investor confidence in the company’s growth trajectory. However, the low percentage of FII participation could be a concern, as it suggests limited foreign interest, which may affect liquidity and market perception. Enhancing transparency and growth prospects could attract more institutional investors in the future.
Outlook, Risks, and Final Insight
Looking ahead, Krishana Phoschem Ltd is positioned for growth, bolstered by strong revenue trends and solid profitability metrics. However, risks remain, particularly concerning its operational efficiency and high reliance on domestic agricultural demand. The company must address its cash conversion cycle to improve liquidity and operational efficiency. Additionally, fluctuations in raw material prices and changing regulatory landscapes in the fertiliser sector could impact margins. If Krishana Phoschem can capitalize on its current momentum while effectively managing these risks, it may continue to deliver strong financial results. Conversely, failure to enhance operational efficiencies or adapt to market changes might hinder its growth potential. Overall, while the company has a positive outlook, it must remain vigilant to sustain its upward trajectory amidst evolving market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 6,927 Cr. | 174 | 221/156 | 10.4 | 313 | 2.88 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 138 Cr. | 26.2 | 73.0/24.8 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 102 Cr. | 11.2 | 18.7/10.4 | 20.2 | 20.0 | 0.45 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,193 Cr. | 284 | 395/155 | 3.45 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,589 Cr. | 78.0 | 128/72.0 | 8.55 | 63.8 | 2.56 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,450.76 Cr | 383.02 | 47.15 | 185.72 | 0.99% | 13.03% | 10.58% | 6.96 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 65 | 47 | 145 | 165 | 265 | 230 | 263 | 281 | 301 | 304 | 473 | 396 | 608 |
| Expenses | 50 | 38 | 127 | 133 | 218 | 207 | 238 | 239 | 260 | 260 | 417 | 330 | 535 |
| Operating Profit | 15 | 9 | 19 | 32 | 47 | 24 | 26 | 42 | 40 | 44 | 56 | 66 | 73 |
| OPM % | 24% | 18% | 13% | 20% | 18% | 10% | 10% | 15% | 13% | 15% | 12% | 17% | 12% |
| Other Income | 0 | 1 | 1 | 1 | -1 | 0 | 1 | 1 | 2 | 2 | 6 | 3 | 3 |
| Interest | 2 | 1 | 3 | 7 | 10 | 9 | 11 | 12 | 10 | 9 | 8 | 9 | 7 |
| Depreciation | 2 | 2 | 2 | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 9 |
| Profit before tax | 12 | 6 | 14 | 18 | 28 | 6 | 7 | 23 | 25 | 29 | 47 | 51 | 61 |
| Tax % | 17% | 18% | 56% | 33% | 32% | 41% | 17% | 28% | 32% | 29% | 30% | 40% | 45% |
| Net Profit | 10 | 5 | 6 | 12 | 19 | 4 | 6 | 16 | 17 | 21 | 33 | 31 | 33 |
| EPS in Rs | 1.65 | 0.78 | 1.05 | 2.00 | 3.25 | 0.61 | 0.92 | 2.71 | 2.76 | 3.39 | 5.43 | 5.05 | 5.48 |
Last Updated: December 30, 2025, 5:32 am
Below is a detailed analysis of the quarterly data for Krishana Phoschem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 608.00 Cr.. The value appears strong and on an upward trend. It has increased from 396.00 Cr. (Jun 2025) to 608.00 Cr., marking an increase of 212.00 Cr..
- For Expenses, as of Sep 2025, the value is 535.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 330.00 Cr. (Jun 2025) to 535.00 Cr., marking an increase of 205.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 66.00 Cr. (Jun 2025) to 73.00 Cr., marking an increase of 7.00 Cr..
- For OPM %, as of Sep 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Jun 2025) to 12.00%, marking a decrease of 5.00%.
- For Other Income, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Interest, as of Sep 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.00 Cr. (Jun 2025) to 7.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Jun 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Jun 2025) to 61.00 Cr., marking an increase of 10.00 Cr..
- For Tax %, as of Sep 2025, the value is 45.00%. The value appears to be increasing, which may not be favorable. It has increased from 40.00% (Jun 2025) to 45.00%, marking an increase of 5.00%.
- For Net Profit, as of Sep 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Jun 2025) to 33.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.48. The value appears strong and on an upward trend. It has increased from 5.05 (Jun 2025) to 5.48, marking an increase of 0.43.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:04 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 90 | 73 | 89 | 80 | 96 | 146 | 162 | 188 | 318 | 323 | 923 | 1,355 | 1,780 |
| Expenses | 75 | 63 | 77 | 64 | 77 | 112 | 127 | 149 | 263 | 271 | 795 | 1,171 | 1,541 |
| Operating Profit | 15 | 10 | 12 | 15 | 19 | 33 | 35 | 39 | 56 | 52 | 128 | 184 | 239 |
| OPM % | 17% | 13% | 13% | 19% | 20% | 23% | 22% | 21% | 17% | 16% | 14% | 14% | 13% |
| Other Income | 0 | 4 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 3 | 2 | 10 | 14 |
| Interest | 4 | 5 | 5 | 4 | 6 | 3 | 3 | 2 | 4 | 7 | 37 | 39 | 34 |
| Depreciation | 4 | 3 | 6 | 6 | 8 | 11 | 12 | 10 | 10 | 9 | 34 | 31 | 32 |
| Profit before tax | 8 | 5 | 3 | 6 | 6 | 19 | 21 | 28 | 43 | 39 | 59 | 123 | 188 |
| Tax % | 33% | 43% | 54% | 46% | 44% | 29% | 34% | 31% | 31% | 31% | 32% | 30% | |
| Net Profit | 5 | 3 | 1 | 3 | 4 | 14 | 14 | 20 | 29 | 27 | 40 | 87 | 117 |
| EPS in Rs | 1.40 | 0.70 | 0.33 | 0.66 | 0.71 | 2.71 | 2.77 | 3.75 | 4.97 | 4.51 | 6.68 | 14.29 | 19.35 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 7% | 5% | 6% | 8% | 4% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -40.00% | -66.67% | 200.00% | 33.33% | 250.00% | 0.00% | 42.86% | 45.00% | -6.90% | 48.15% | 117.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.67% | 266.67% | -166.67% | 216.67% | -250.00% | 42.86% | 2.14% | -51.90% | 55.04% | 69.35% |
Krishana Phoschem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 53% |
| 3 Years: | 62% |
| TTM: | 42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 44% |
| 3 Years: | 43% |
| TTM: | 124% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 81% |
| 3 Years: | 53% |
| 1 Year: | 120% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 9:25 am
Balance Sheet
Last Updated: December 10, 2025, 2:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 21 | 21 | 25 | 25 | 25 | 25 | 26 | 30 | 31 | 62 | 62 | 62 |
| Reserves | 48 | 52 | 59 | 68 | 71 | 85 | 100 | 121 | 191 | 231 | 239 | 322 | 383 |
| Borrowings | 29 | 30 | 32 | 46 | 42 | 32 | 12 | 21 | 70 | 276 | 436 | 376 | 413 |
| Other Liabilities | 18 | 19 | 5 | 14 | 11 | 29 | 21 | 27 | 39 | 44 | 108 | 276 | 413 |
| Total Liabilities | 112 | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 | 1,270 |
| Fixed Assets | 74 | 72 | 72 | 80 | 112 | 106 | 96 | 94 | 85 | 358 | 322 | 295 | 280 |
| CWIP | 0 | 9 | 8 | 25 | 0 | 1 | 0 | 7 | 92 | 3 | 43 | 78 | 89 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 38 | 42 | 37 | 48 | 37 | 64 | 62 | 94 | 153 | 220 | 479 | 664 | 901 |
| Total Assets | 112 | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 | 1,270 |
Below is a detailed analysis of the balance sheet data for Krishana Phoschem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 62.00 Cr..
- For Reserves, as of Sep 2025, the value is 383.00 Cr.. The value appears strong and on an upward trend. It has increased from 322.00 Cr. (Mar 2025) to 383.00 Cr., marking an increase of 61.00 Cr..
- For Borrowings, as of Sep 2025, the value is 413.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 376.00 Cr. (Mar 2025) to 413.00 Cr., marking an increase of 37.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 413.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 276.00 Cr. (Mar 2025) to 413.00 Cr., marking an increase of 137.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,270.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,036.00 Cr. (Mar 2025) to 1,270.00 Cr., marking an increase of 234.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 280.00 Cr.. The value appears to be declining and may need further review. It has decreased from 295.00 Cr. (Mar 2025) to 280.00 Cr., marking a decrease of 15.00 Cr..
- For CWIP, as of Sep 2025, the value is 89.00 Cr.. The value appears strong and on an upward trend. It has increased from 78.00 Cr. (Mar 2025) to 89.00 Cr., marking an increase of 11.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 901.00 Cr.. The value appears strong and on an upward trend. It has increased from 664.00 Cr. (Mar 2025) to 901.00 Cr., marking an increase of 237.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,270.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,036.00 Cr. (Mar 2025) to 1,270.00 Cr., marking an increase of 234.00 Cr..
However, the Borrowings (413.00 Cr.) are higher than the Reserves (383.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -14.00 | -20.00 | -20.00 | -31.00 | -23.00 | 1.00 | 23.00 | 18.00 | -14.00 | -224.00 | -308.00 | -192.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 8 | 24 | 62 | 66 | 52 | 53 | 41 | 54 | 60 | 84 | 104 | 102 |
| Inventory Days | 223 | 290 | 97 | 224 | 127 | 157 | 135 | 145 | 103 | 194 | 84 | 60 |
| Days Payable | 72 | 115 | 20 | 94 | 43 | 85 | 22 | 41 | 39 | 16 | 35 | 67 |
| Cash Conversion Cycle | 159 | 200 | 139 | 195 | 136 | 126 | 154 | 158 | 124 | 263 | 154 | 95 |
| Working Capital Days | 17 | 36 | 49 | 57 | 22 | 52 | 87 | 95 | 95 | 64 | 44 | 42 |
| ROCE % | 14% | 11% | 7% | 8% | 9% | 16% | 17% | 20% | 20% | 11% | 15% | 22% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 14.00 | 6.54 | 8.80 | 10.50 | 7.83 |
| Diluted EPS (Rs.) | 14.00 | 6.54 | 8.65 | 10.42 | 7.15 |
| Cash EPS (Rs.) | 19.04 | 12.07 | 11.46 | 13.34 | 11.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 62.08 | 48.62 | 84.69 | 74.58 | 56.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 62.08 | 48.62 | 84.69 | 74.58 | 56.36 |
| Dividend / Share (Rs.) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Revenue From Operations / Share (Rs.) | 219.68 | 149.43 | 104.43 | 107.75 | 72.31 |
| PBDIT / Share (Rs.) | 31.36 | 21.02 | 17.61 | 19.20 | 15.68 |
| PBIT / Share (Rs.) | 26.32 | 15.50 | 14.80 | 15.80 | 11.75 |
| PBT / Share (Rs.) | 19.94 | 9.55 | 12.60 | 14.43 | 10.88 |
| Net Profit / Share (Rs.) | 14.00 | 6.54 | 8.65 | 9.94 | 7.50 |
| PBDIT Margin (%) | 14.27 | 14.06 | 16.86 | 17.81 | 21.67 |
| PBIT Margin (%) | 11.98 | 10.37 | 14.17 | 14.66 | 16.25 |
| PBT Margin (%) | 9.07 | 6.39 | 12.06 | 13.39 | 15.04 |
| Net Profit Margin (%) | 6.37 | 4.37 | 8.28 | 9.22 | 10.37 |
| Return on Networth / Equity (%) | 22.54 | 13.45 | 10.21 | 13.32 | 13.31 |
| Return on Capital Employeed (%) | 27.68 | 19.62 | 10.73 | 16.87 | 19.03 |
| Return On Assets (%) | 8.35 | 4.78 | 4.59 | 8.93 | 10.01 |
| Long Term Debt / Equity (X) | 0.34 | 0.52 | 0.55 | 0.22 | 0.04 |
| Total Debt / Equity (X) | 0.97 | 1.45 | 1.06 | 0.31 | 0.10 |
| Asset Turnover Ratio (%) | 1.44 | 1.29 | 0.70 | 1.22 | 1.07 |
| Current Ratio (X) | 1.41 | 1.33 | 1.36 | 2.58 | 2.43 |
| Quick Ratio (X) | 1.08 | 0.92 | 0.65 | 1.52 | 1.24 |
| Inventory Turnover Ratio (X) | 9.33 | 4.61 | 1.86 | 3.14 | 2.57 |
| Dividend Payout Ratio (NP) (%) | 3.57 | 3.82 | 5.54 | 4.64 | 6.35 |
| Dividend Payout Ratio (CP) (%) | 2.62 | 2.07 | 4.18 | 3.46 | 4.17 |
| Earning Retention Ratio (%) | 96.43 | 96.18 | 94.46 | 95.36 | 93.65 |
| Cash Earning Retention Ratio (%) | 97.38 | 97.93 | 95.82 | 96.54 | 95.83 |
| Interest Coverage Ratio (X) | 4.91 | 3.54 | 7.98 | 14.05 | 17.99 |
| Interest Coverage Ratio (Post Tax) (X) | 3.19 | 2.10 | 4.92 | 8.27 | 9.61 |
| Enterprise Value (Cr.) | 1801.75 | 1938.86 | 1779.52 | 892.61 | 259.52 |
| EV / Net Operating Revenue (X) | 1.33 | 2.10 | 5.51 | 2.79 | 1.38 |
| EV / EBITDA (X) | 9.29 | 14.92 | 32.69 | 15.69 | 6.34 |
| MarketCap / Net Operating Revenue (X) | 1.07 | 1.63 | 4.66 | 2.58 | 1.30 |
| Retention Ratios (%) | 96.42 | 96.17 | 94.45 | 95.35 | 93.64 |
| Price / BV (X) | 3.79 | 5.02 | 5.74 | 3.73 | 1.66 |
| Price / Net Operating Revenue (X) | 1.07 | 1.63 | 4.66 | 2.58 | 1.30 |
| EarningsYield | 0.05 | 0.02 | 0.01 | 0.03 | 0.08 |
After reviewing the key financial ratios for Krishana Phoschem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.04. This value is within the healthy range. It has increased from 12.07 (Mar 24) to 19.04, marking an increase of 6.97.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 62.08. It has increased from 48.62 (Mar 24) to 62.08, marking an increase of 13.46.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 62.08. It has increased from 48.62 (Mar 24) to 62.08, marking an increase of 13.46.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 219.68. It has increased from 149.43 (Mar 24) to 219.68, marking an increase of 70.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 31.36. This value is within the healthy range. It has increased from 21.02 (Mar 24) to 31.36, marking an increase of 10.34.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.32. This value is within the healthy range. It has increased from 15.50 (Mar 24) to 26.32, marking an increase of 10.82.
- For PBT / Share (Rs.), as of Mar 25, the value is 19.94. This value is within the healthy range. It has increased from 9.55 (Mar 24) to 19.94, marking an increase of 10.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For PBDIT Margin (%), as of Mar 25, the value is 14.27. This value is within the healthy range. It has increased from 14.06 (Mar 24) to 14.27, marking an increase of 0.21.
- For PBIT Margin (%), as of Mar 25, the value is 11.98. This value is within the healthy range. It has increased from 10.37 (Mar 24) to 11.98, marking an increase of 1.61.
- For PBT Margin (%), as of Mar 25, the value is 9.07. This value is below the healthy minimum of 10. It has increased from 6.39 (Mar 24) to 9.07, marking an increase of 2.68.
- For Net Profit Margin (%), as of Mar 25, the value is 6.37. This value is within the healthy range. It has increased from 4.37 (Mar 24) to 6.37, marking an increase of 2.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 22.54. This value is within the healthy range. It has increased from 13.45 (Mar 24) to 22.54, marking an increase of 9.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 27.68. This value is within the healthy range. It has increased from 19.62 (Mar 24) to 27.68, marking an increase of 8.06.
- For Return On Assets (%), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 4.78 (Mar 24) to 8.35, marking an increase of 3.57.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.34. This value is within the healthy range. It has decreased from 0.52 (Mar 24) to 0.34, marking a decrease of 0.18.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.97. This value is within the healthy range. It has decreased from 1.45 (Mar 24) to 0.97, marking a decrease of 0.48.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.44. It has increased from 1.29 (Mar 24) to 1.44, marking an increase of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has increased from 1.33 (Mar 24) to 1.41, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 1.08, marking an increase of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 8. It has increased from 4.61 (Mar 24) to 9.33, marking an increase of 4.72.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 20. It has decreased from 3.82 (Mar 24) to 3.57, marking a decrease of 0.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.62. This value is below the healthy minimum of 20. It has increased from 2.07 (Mar 24) to 2.62, marking an increase of 0.55.
- For Earning Retention Ratio (%), as of Mar 25, the value is 96.43. This value exceeds the healthy maximum of 70. It has increased from 96.18 (Mar 24) to 96.43, marking an increase of 0.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.38. This value exceeds the healthy maximum of 70. It has decreased from 97.93 (Mar 24) to 97.38, marking a decrease of 0.55.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.91. This value is within the healthy range. It has increased from 3.54 (Mar 24) to 4.91, marking an increase of 1.37.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.19. This value is within the healthy range. It has increased from 2.10 (Mar 24) to 3.19, marking an increase of 1.09.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,801.75. It has decreased from 1,938.86 (Mar 24) to 1,801.75, marking a decrease of 137.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 2.10 (Mar 24) to 1.33, marking a decrease of 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 9.29. This value is within the healthy range. It has decreased from 14.92 (Mar 24) to 9.29, marking a decrease of 5.63.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.07, marking a decrease of 0.56.
- For Retention Ratios (%), as of Mar 25, the value is 96.42. This value exceeds the healthy maximum of 70. It has increased from 96.17 (Mar 24) to 96.42, marking an increase of 0.25.
- For Price / BV (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 5.02 (Mar 24) to 3.79, marking a decrease of 1.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.07, marking a decrease of 0.56.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.05, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Krishana Phoschem Ltd:
- Net Profit Margin: 6.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 27.68% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 22.54% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.4 (Industry average Stock P/E: 47.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.97
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.37%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | Wing A/2, 1st Floor, Ostwal Heights, Urban Forest, Atun, Bhilwara Rajasthan 311802 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mahendra Kumar Ostwal | Chairman & Non-Exe.Director |
| Mr. Praveen Ostwal | Managing Director |
| Mr. Sunil Kothari | WholeTime Director & CFO |
| Mr. Pankaj Ostwal | Non Executive Director |
| Mr. Bheru Lal Ostwal | Independent Director |
| Mrs. Shruti Babel | Independent Director |
| Mr. Gopal Inani | Independent Director |
| Mrs. Priyanka Surana | Independent Director |
FAQ
What is the intrinsic value of Krishana Phoschem Ltd?
Krishana Phoschem Ltd's intrinsic value (as of 18 January 2026) is ₹437.17 which is 9.11% lower the current market price of ₹481.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,915 Cr. market cap, FY2025-2026 high/low of ₹619/175, reserves of ₹383 Cr, and liabilities of ₹1,270 Cr.
What is the Market Cap of Krishana Phoschem Ltd?
The Market Cap of Krishana Phoschem Ltd is 2,915 Cr..
What is the current Stock Price of Krishana Phoschem Ltd as on 18 January 2026?
The current stock price of Krishana Phoschem Ltd as on 18 January 2026 is ₹481.
What is the High / Low of Krishana Phoschem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Krishana Phoschem Ltd stocks is ₹619/175.
What is the Stock P/E of Krishana Phoschem Ltd?
The Stock P/E of Krishana Phoschem Ltd is 22.4.
What is the Book Value of Krishana Phoschem Ltd?
The Book Value of Krishana Phoschem Ltd is 73.4.
What is the Dividend Yield of Krishana Phoschem Ltd?
The Dividend Yield of Krishana Phoschem Ltd is 0.10 %.
What is the ROCE of Krishana Phoschem Ltd?
The ROCE of Krishana Phoschem Ltd is 21.7 %.
What is the ROE of Krishana Phoschem Ltd?
The ROE of Krishana Phoschem Ltd is 25.3 %.
What is the Face Value of Krishana Phoschem Ltd?
The Face Value of Krishana Phoschem Ltd is 10.0.